TAIJI
LIVE

Serial Number

76239304

Owner

TAIJI GROUP,CHONGQING FULING PHARMACEUTICAL FACTORY

Attorney

Nazly Aileen Bayramoglu

First Use Date

Mar 18, 1986

Filing Date

Apr 11, 2001

Add to watchlist:

No watchlists yet
View on USPTO

TAIJI Trademark

Serial Number: 76239304 • Registration: 2869995

TAIJI is a trademark filed by TAIJI GROUP,CHONGQING FULING PHARMACEUTICAL FACTORY on April 11, 2001. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

TAIJI GROUP,CHONGQING FULING PHARMACEUTICAL FACTORY

NO. 1 TAIJI ROAD
CHONGQING 408000 , CN

Entity Type: 03

TAI JI GROUP FU LING PHARMACEUTICAL FACTORY

No.68, Jian She Road
Chongqing , CN

Entity Type: 99

Trademark Details

Filing Date

April 11, 2001

Registration Date

August 3, 2004

First Use Anywhere

March 18, 1986

First Use in Commerce

May 20, 2000

Published for Opposition

May 13, 2003

Goods & Services

Medicinal preparations for human use for use in the treatment of hypertension, headaches, [ dermatological diseases, ] cardiovascular diseases, [ lymphatic diseases, psychiatric diseases, skeletal diseases, muscular diseases, cancer, ] gastrointestinal diseases, [ allergies, insomnia, depression, anxiety, stress, urological diseases, diabetes, ] heart diseases, [ hepatitis, infectious diseases, arthritis, acne, neurological disease, of the nervous system, eye conditions, tendonitis, treatment of libido problems; pharmaceutical preparations of microorganisms for medical use in treating humans and for veterinary use in treating livestock, domesticated pets, and domesticated animals, for use in the treatment of hypertension, headaches, dermatological diseases, cardiovascular diseases, lymphatic diseases, psychiatric diseases, skeletal diseases, muscular diseases, cancer, gastrointestinal diseases, allergies, insomnia, depression, anxiety, stress, urological diseases, diabetes, heart diseases, hepatitis, infectious diseases, arthritis, acne, neurological diseases of the nervous system, eye conditions, tendonitis, treatment of libido problems; pharmaceutical preparations of organisms for use in the treatment of hypertension, headaches, dermatological diseases, cardiovascular diseases, lymphatic diseases, psychiatric diseases, skeletal diseases, muscular diseases, cancer, gastrointestinal diseases, allergies insomnia depression, anxiety, stress, urological diseases, diabetes, heart diseases, hepatitis, infectious diseases, arthritis, acne, neurological diseases of the nervous system, eye conditions, tendonitis, treatment of libido problems; ] drugs for medical use, namely, medications used to treat hypertension, headaches, [ dermatological diseases, ] cardiovascular diseases, [ lymphatic diseases, psychiatric diseases, skeletal diseases, muscular diseases, cancer, ] gastrointestinal diseases, [ allergies, insomnia, depression, anxiety, stress, urological diseases, diabetes, ] heart diseases [ , hepatitis, infectious diseases, arthritis, acne, neurological diseases of the nervous system, eye conditions, tendonitis, treatment of libido problems; foods for medically restricted diets ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jul 27, 2025 NA89
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Jul 27, 2025 RNL2
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jul 27, 2025 89AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Feb 25, 2025 EROP
OFFICE ACTION ISSUED POU1
Aug 26, 2024 PUM1
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 26, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Aug 1, 2024 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 3, 2023 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 30, 2013 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 30, 2013 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 30, 2013 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 30, 2013 APRE
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Sep 27, 2013 89AF
TEAS SECTION 8 & 9 RECEIVED
Sep 27, 2013 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 27, 2013 TCCA
WITHDRAWAL OF ATTORNEY GRANTED
Oct 6, 2009 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Oct 6, 2009 WOAR
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Sep 30, 2009 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 30, 2009 APRE
TEAS SECTION 8 RECEIVED
Sep 1, 2009 ES8R
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 15, 2009 ASGN
REGISTERED-PRINCIPAL REGISTER
Aug 3, 2004 R.PR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 25, 2004 CNPR
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 4, 2004 CRFA
FAX RECEIVED
May 4, 2004 FAXX
NON-FINAL ACTION MAILED
Mar 22, 2004 CNRT
ASSIGNED TO EXAMINER
Mar 19, 2004 DOCK
CASE FILE IN TICRS
Mar 18, 2004 CFIT
STATEMENT OF USE PROCESSING COMPLETE
Mar 10, 2004 SUPC
PAPER RECEIVED
Feb 9, 2004 MAIL
USE AMENDMENT FILED
Feb 5, 2004 IUAF
NOA MAILED - SOU REQUIRED FROM APPLICANT
Aug 5, 2003 NOAM
PUBLISHED FOR OPPOSITION
May 13, 2003 PUBO
NOTICE OF PUBLICATION
Apr 23, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 7, 2003 CNSA
EXAMINERS AMENDMENT MAILED
Feb 3, 2003 CNEA
FINAL REFUSAL MAILED
Nov 1, 2002 CNFR
ASSIGNED TO EXAMINER
Sep 30, 2002 DOCK
REINSTATED
Sep 27, 2002 REIN
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 13, 2002 CRFA
PETITION TO REVIVE-RECEIVED
Jun 13, 2002 PETR
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 7, 2002 ABN2
NON-FINAL ACTION MAILED
Aug 15, 2001 CNRT
ASSIGNED TO EXAMINER
Jul 20, 2001 DOCK